These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 32045827)
1. Active vitamin D and vitamin D analogs stimulate fibroblast growth factor 23 production in osteocyte-like cells via the vitamin D receptor. Yashiro M; Ohya M; Mima T; Nakashima Y; Kawakami K; Yamamoto S; Kobayashi S; Yano T; Tanaka Y; Sonou T; Tatsuta K; Negi S; Shigematsu T J Pharm Biomed Anal; 2020 Apr; 182():113139. PubMed ID: 32045827 [TBL] [Abstract][Full Text] [Related]
2. In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells. Ratsma DMA; Muller M; Koedam M; Zillikens MC; van der Eerden BCJ Eur J Endocrinol; 2023 Oct; 189(4):448-459. PubMed ID: 37796032 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone. Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240 [TBL] [Abstract][Full Text] [Related]
5. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors. Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946 [TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. Barthel TK; Mathern DR; Whitfield GK; Haussler CA; Hopper HA; Hsieh JC; Slater SA; Hsieh G; Kaczmarska M; Jurutka PW; Kolek OI; Ghishan FK; Haussler MR J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):381-8. PubMed ID: 17293108 [TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6. Saini RK; Kaneko I; Jurutka PW; Forster R; Hsieh A; Hsieh JC; Haussler MR; Whitfield GK Calcif Tissue Int; 2013 Apr; 92(4):339-53. PubMed ID: 23263654 [TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis. Yang R; Chen J; Zhang J; Qin R; Wang R; Qiu Y; Mao Z; Goltzman D; Miao D Aging Cell; 2020 Feb; 19(2):e13095. PubMed ID: 31880094 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105 [TBL] [Abstract][Full Text] [Related]
10. NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling. Jagga S; Hughes A; Manoochehri Arash N; Sorsby M; Brooks DJ; Divieti Pajevic P; Liu ES Endocrinology; 2024 Jul; 165(8):. PubMed ID: 39024412 [TBL] [Abstract][Full Text] [Related]
11. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo. Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399 [TBL] [Abstract][Full Text] [Related]
12. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption. Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161 [TBL] [Abstract][Full Text] [Related]
13. Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells. Ito N; Findlay DM; Anderson PH; Bonewald LF; Atkins GJ J Steroid Biochem Mol Biol; 2013 Jul; 136():183-6. PubMed ID: 23064198 [TBL] [Abstract][Full Text] [Related]
14. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23. Sapir-Koren R; Livshits G Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227 [TBL] [Abstract][Full Text] [Related]
15. 1ɑ,25-Dihydroxyvitamin D Luo W; Jiang Y; Yi Z; Wu Y; Gong P; Xiong Y J Cell Mol Med; 2021 Apr; 25(8):4148-4156. PubMed ID: 33609082 [TBL] [Abstract][Full Text] [Related]
16. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor. Messerlian S; Gao X; St-Arnaud R J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635 [TBL] [Abstract][Full Text] [Related]
17. The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone. St John HC; Bishop KA; Meyer MB; Benkusky NA; Leng N; Kendziorski C; Bonewald LF; Pike JW Mol Endocrinol; 2014 Jul; 28(7):1150-65. PubMed ID: 24877565 [TBL] [Abstract][Full Text] [Related]
18. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Prié D; Friedlander G Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257 [TBL] [Abstract][Full Text] [Related]
19. 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro. Yamamoto R; Minamizaki T; Yoshiko Y; Yoshioka H; Tanne K; Aubin JE; Maeda N J Endocrinol; 2010 Sep; 206(3):279-86. PubMed ID: 20530653 [TBL] [Abstract][Full Text] [Related]